1.
Rev. Hosp. Clin. Univ. Chile
;
20(3): 194-198, 2009. ilus
Artigo
em Espanhol
| LILACS
| ID: lil-620963
RESUMO
Stroke is a devastating disease with a high mortality and high degree of disability. In the nineties a new specific treatment was proved to be beneficial, the intravenous recombinant tisular plasminogen activator (IV r-TPA). The first notion of pharmacologic vessel revascularization marked a new era in stroke treatment. However, there are cases that need a more aggressive approach, such as large intracranial vessel occlusion. Recently, new endovascular approaches and an explosive development of devices to remove or suck the thrombus, bring a second revolution in the manner that we treat stroke.